4//SEC Filing
GARNICK ROBERT L 4
Accession 0001683168-21-000320
CIK 0000836564other
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 5:30 PM ET
Size
7.8 KB
Accession
0001683168-21-000320
Insider Transaction Report
Form 4
GARNICK ROBERT L
Director
Transactions
- Conversion
Series A Convertible Voting Preferred Stock
2021-01-29−35,000→ 0 total→ Common Stock (356,794 underlying) - Conversion
Common Stock
2021-01-29+356,794→ 356,794 total
Footnotes (2)
- [F1]Each share of the Series A Convertible Voting Preferred Stock automatically converted for no additional consideration into 10.194106 shares of common stock on January 29, 2021, the date that both of the following criteria were met: (i) upon the Registrant having a sufficient number of authorized and unissued shares of common stock so as to permit the conversion of all outstanding shares of the Series A Convertible Voting Preferred Stock into common stock, which occurred on December 2, 2020 in conjunction with the reverse stock split; and (ii) the effectiveness of any registration statement registering the resale of the underlying shares of common stock of the Registrant, which occurred on January 29, 2021.
- [F2]The Series A Convertible Voting Preferred Stock has no expiration date.
Documents
Issuer
Mosaic ImmunoEngineering Inc.
CIK 0000836564
Entity typeother
Related Parties
1- filerCIK 0001214124
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 5:30 PM ET
- Size
- 7.8 KB